Integra LifeSciences Holdings (IART)

Debt-to-capital ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands 1,087,920 1,395,820 1,300,490 1,388,680 1,408,220
Total stockholders’ equity US$ in thousands 1,545,280 1,587,880 1,804,400 1,684,800 1,514,870
Debt-to-capital ratio 0.41 0.47 0.42 0.45 0.48

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,087,920K ÷ ($1,087,920K + $1,545,280K)
= 0.41

The debt-to-capital ratio for Integra LifeSciences Holdings has shown a gradual decrease from 0.48 as of December 31, 2020, to 0.41 as of December 31, 2024. This indicates that over the 5-year period, the company has been effectively managing its debt relative to its total capital. A decreasing trend in the ratio suggests that the company may be reducing its reliance on debt financing in favor of equity financing, which can enhance financial stability and reduce financial risk. The ratio of 0.41 as of December 31, 2024, indicates that 41% of the company's capital structure is comprised of debt, while the remaining 59% is equity. Overall, the decreasing trend in the debt-to-capital ratio suggests a positive financial health for Integra LifeSciences Holdings.